行情

ARCT

ARCT

Arcturus
NASDAQ

实时行情|Nasdaq Last Sale

14.93
+0.18
+1.22%
休市 16:00 02/21 EST
开盘
14.73
昨收
14.75
最高
15.01
最低
14.23
成交量
7.25万
成交额
--
52周最高
15.65
52周最低
4.255
市值
2.26亿
市盈率(TTM)
-10.5819
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ARCT价格均价为19.88,最高价位25.00,最低价为14.00。

EPS

ARCT 新闻

更多
  • The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion
  • Benzinga · 1天前
  • Arcturus Therapeutics to Present at Two Investor Conferences in March
  • GlobeNewswire · 3天前
  • Benzinga's Top Upgrades, Downgrades For February 11, 2020
  • Benzinga · 02/11 14:39
  • Argus upgrades Regeneron in premarket analyst action
  • Seeking Alpha - Article · 02/11 12:54

所属板块

生物技术和医学研究
+0.37%
制药与医学研究
+0.54%

热门股票

代码
价格
涨跌幅
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

ARCT 简况

Arcturus Therapeutics Holdings Inc. is a ribonucleic acid (RNA) medicines company focused on liver and respiratory diseases. In addition to its internal messenger RNA (mRNA) platform, its lipid nanoparticle deliver system, LUNAR, enables multiple nucleic acid medicines. It is expertized in the discovery and development of RNA medicines, including in the production of RNA drug substance and nanoparticle-formulated drug product. It has a pipeline of seven drugs in the late-stage discovery and early-stage development out of which two are wholly-owned and five are pharma partnered programs. It is focused on applying its technologies to develop RNA medicines in multiple therapeutic approaches, which include mRNA, deoxyribonucleic acid (DNA), and replicon protein replacement for therapeutics and protein delivery for vaccines; small interfering RNA (siRNA), microRNA, and antisense oligonucleotides knockdown of genes overexpressed in disease; and CRISPR, TALEN and zinc finger proteins.
展开

微牛提供Arcturus Therapeutics Ltd(NASDAQ-ARCT)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ARCT股票新闻,以帮助您做出投资决策。